Nasdaq & Leerink Partners
10 shared events · Importance 3 · Last updated Aug 07, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Nasdaq: Nasdaq will list BlossomHill Therapeutics' shares under the ticker 'BLSM', adding a new biotech company to its exchange. This listing is a routine but positive addition to its roster.
Leerink Partners: Leerink Partners served as a lead book-running manager, generating underwriting revenue and reinforcing its expertise in healthcare IPOs. The deal enhances its reputation in the sector.
Aug 07, 2026 · 8 articles
Business
Nasdaq: Nasdaq is the exchange where Scribe's shares began trading, benefiting from listing fees and increased trading activity.
Leerink Partners: Leerink Partners acted as a joint book-running manager for the IPO, earning fees and enhancing its reputation in biotech capital markets.
Jul 06, 2026 · 25 articles
Business
Nasdaq: Kazia's ADSs are listed on Nasdaq, and the offering may affect trading activity. The exchange benefits from listing fees and trading volume.
Leerink Partners: Leerink Partners acted as joint bookrunning manager, earning underwriting fees and strengthening its relationship with Kazia. The successful offering enhances its reputation in biotech capital markets.
Jul 20, 2026 · 22 articles
Business
Nasdaq: The combined company will be listed on Nasdaq under the ticker SLTE, providing a public market for the new entity.
Leerink Partners: Leerink Partners acted as financial advisor to Fulcrum Therapeutics in the merger.
Aug 17, 2026 · 6 articles
Business
Nasdaq: Nasdaq is the exchange on which Quoin Pharmaceuticals' ADSs are listed; the company must comply with Nasdaq rules regarding the minimum price.
Leerink Partners: Leerink Partners acted as lead placement agent for the private placement, facilitating the transaction and earning fees.
Aug 28, 2026 · 6 articles
Business
Nasdaq: Nasdaq is the exchange where Beta Bionics' common stock trades under the ticker BBNX, hosting the newly issued shares.
Leerink Partners: Leerink Partners served as a joint book-running manager for the offering, adding to its healthcare-focused investment banking deal flow.
Sep 15, 2026 · 7 articles
Business
Nasdaq: XOMA Royalty common stock delisted from Nasdaq upon completion.
Leerink Partners: Served as lead financial advisor to XOMA Royalty.
Jul 14, 2026 · 6 articles
Business
Nasdaq: Exchange where Lisata shares trade; LSTA closed at $1.47 before the announcement.
Leerink Partners: Served as financial advisor to Marea on the acquisition.
Sep 17, 2026 · 6 articles
Business
Nasdaq: SpaceX is listed on Nasdaq, and its stock performance affects the exchange's indices.
Leerink Partners: Leerink Partners has a neutral rating and a $131 price target, citing regulatory and technology uncertainties.
Jun 18, 2026 · 319 articles
Business
Nasdaq: Both Vertex and Crinetics are listed on Nasdaq. The acquisition may affect trading volumes and index composition, but the exchange itself is not materially impacted.
Leerink Partners: Investment bank; previously commented on Palsonify's approval.
Jul 06, 2026 · 34 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Nasdaq and Leerink Partners interact across events, view sentiment trends, and discover connected entities.
Open Dashboard